Resveratrol

What Is Resveratrol?

Resveratrol (3,5,4’-trihydroxystilbene) is a polyphenolic phytoalexin produced by plants as a defense response to fungal infection, UV radiation, and physical stress. It exists in two forms:

• Trans-resveratrol (biologically active): The naturally occurring form from grapes, red wine, and plant stress responses
• Cis-resveratrol (biologically inert): An isomer produced by heat or photodegradation; lacks SIRT1 activation capacity

Natural Sources:

• Red grapes and red wine: 0.5-5 mg/L (varies by vintage and region)
• Japanese knotweed: 1-2 g per 100g (highest natural concentration)
• Peanuts, blueberries, mulberries: 0.1-1 mg per 100g

Bioavailability Challenge: Oral trans-resveratrol has notoriously poor bioavailability (0.5-5% depending on formulation), yet systemic effects are well-documented at moderate doses. This paradox is explained by:

1. Microbial metabolism: Gut bacteria convert resveratrol to highly bioavailable metabolites (dihydroresveratrol, resveratrol sulfates)
2. Enterohepatic circulation: Resveratrol is reabsorbed in small intestine, recycled through liver
3. Tissue accumulation: Despite low serum levels, resveratrol accumulates in target tissues (mitochondria, nucleus) at 10-100x serum concentration
4. Metabolite activity: Sulfated and glucuronidated forms retain or exceed parent compound bioactivity

Biohacker Implication: Taking resveratrol with food enhances immediate absorption, but fasting may enhance microbial metabolism and enterohepatic circulation for better long-term systemic effects.

Benefits

SIRT1 Activation and Sirtuins

Resveratrol’s primary mechanism is direct SIRT1 activation (at 10-20 µM concentrations), a NAD+-dependent histone deacetylase central to longevity and metabolic health.

SIRT1-Mediated Longevity Pathways:

• PGC-1α deacetylation: Activates mitochondrial biogenesis; increases mitochondrial density by 20-30%
• p53 stabilization: Enhanced tumor suppression without apoptosis in healthy cells
• FoxO transcription factors: Drives antioxidant enzyme expression (SOD, catalase) and autophagy genes
• NF-κB inhibition: Suppresses pro-inflammatory cytokine production
• AMPK activation: Cellular energy sensor; triggers metabolic health pathways

Clinical Translation:

• Activates the same longevity pathways that caloric restriction and exercise activate
• 1000-1500 mg daily approaches the concentration needed for robust SIRT1 activation (10-20 µM)
• Effects plateau around 1500 mg; higher doses show no additional SIRT1 benefit

NAD+ Metabolism and Metabolic Health

• Direct NAD+ substrate: Resveratrol is a substrate for and amplifies SIRT1 activity, which consumes NAD+
• Synergy with NMN/NR: When combined with NAD+ precursors, creates positive feedback loop: NMN restores NAD+ pools → SIRT1 activation → enhanced metabolic health
• Metabolic rate: 1000 mg daily increases resting metabolic rate by 3-5% through mitochondrial biogenesis
• Glucose handling: Improves insulin sensitivity by 15-25% in studies; reduces fasting glucose in prediabetic subjects
• Fat oxidation: Enhances preferential fat utilization during rest and low-intensity activity

Cardiovascular and Vascular Benefits

• Endothelial nitric oxide synthase (eNOS): SIRT1 deacetylates and activates eNOS, improving NO production
• Vascular relaxation: Improved flow-mediated dilation (FMD) by 2-3% in clinical studies
• Arterial compliance: Reduced arterial stiffness; improves pulse wave velocity
• Platelet aggregation: Mild antiplatelet effect (benefit for cardiovascular health; concern if on anticoagulants)
• Blood pressure: 500-1000 mg daily reduces systolic BP by 3-5 mmHg in hypertensive subjects
• LDL modification: Prevents LDL oxidation through antioxidant mechanisms

Longevity and Aging-Related Pathways

Note: Human evidence here is preliminary and several large RCTs have shown no metabolic or cardiovascular benefit. Resveratrol may influence aging-related pathways, but “aging reversal” is not supported by human data.

• Telomere length: Some preliminary evidence suggests resveratrol + NMN may affect telomerase activity; not established in humans
• Cellular senescence: May reduce SASP (senescence-associated secretory phenotype) through NF-κB inhibition
• Epigenetic age: Resveratrol + NMN combination has been studied in relation to DNAm age, but a reduction in biological age is not established in humans
• Autophagy: Activates cellular cleanup mechanisms through SIRT1 and mTOR inhibition
• Protein aggregates: Enhances clearance of misfolded proteins (Alzheimer’s pathology relevance)

Brain and Cognitive Protection

• Blood-brain barrier integrity: Maintains tight junction function; reduces neuroinflammation
• BDNF: Supports brain-derived neurotrophic factor, critical for neuroplasticity and memory
• Amyloid-beta clearance: Enhances microglial phagocytosis of Aβ plaques
• Neuroinflammation: Suppresses microglia activation and cytokine production
• Cognitive reserve: Some observational studies associate dietary polyphenol intake with lower dementia risk, but these do not establish that resveratrol supplementation reduces dementia risk by any specific amount

Metabolic and Body Composition

• Mitochondrial density: Increases mitochondrial number by 20-30% through PGC-1α activation
• VO2 max: Improves aerobic capacity; some evidence suggests 5-10% enhancement in untrained individuals
• Fat loss: Not a direct fat burner, but improves metabolic rate and fat oxidation capacity
• Muscle: Fat ratio: Improves through enhanced mitochondrial function and metabolic partitioning
• AMPK activation: Mimics exercise effect on cellular energy metabolism

Mechanism of Action

SIRT1 Activation (The Central Mechanism)

Direct Binding:

• Resveratrol binds directly to SIRT1’s allosteric site (not the NAD+ binding site)
• Binding induces conformational change increasing SIRT1 catalytic activity 2-5 fold
• Activation is direct and dose-dependent (10-20 µM = maximal activation)
• NAD+ is required cofactor; activation is NAD+-dependent (explains synergy with NMN)

Substrate Specificity: Once activated, SIRT1 deacetylates multiple key proteins:

1. PGC-1α (Master Mitochondrial Regulator):

   • Deacetylation increases activity of PGC-1α
   • Activates NRF1/NRF2 transcription factors
   • Result: 20-30% increase in mitochondrial biogenesis genes (mtDNA, respiratory complex proteins)

2. FoxO Transcription Factors (Stress Resistance):

   • SIRT1 deacetylates FoxO1, FoxO3, FoxO4
   • Increases their activity and nuclear localization
   • Result: Enhanced transcription of antioxidant enzymes (SOD2, catalase), longevity genes, stress resistance

3. p53 (Tumor Suppressor):

   • Deacetylation enhances p53 stability without increasing apoptosis in normal cells
   • Selective activation of p53 target genes (DNA repair, growth arrest) without proapoptotic genes
   • Result: Enhanced cancer prevention without cellular damage

4. NF-κB (Inflammatory Transcription Factor):

   • SIRT1 deacetylates RelA/p65, reducing its transcriptional activity
   • Also deacetylates histones at NF-κB target genes
   • Result: Reduced expression of pro-inflammatory cytokines (IL-6, TNF-α, IL-1β)

5. Metabolic Enzymes:

   • PGC-1α → mitochondrial biogenesis
   • AMPK → energy metabolism optimization
   • Acetyl-CoA synthetase → enhanced fatty acid oxidation

AMPK Activation (Energy Metabolism)

Resveratrol activates AMPK (AMP-activated protein kinase), the cellular energy sensor:

• Mechanism: Indirect; SIRT1 activation upregulates AMPK, and resveratrol may directly activate AMPK through mitochondrial ROS
• Effects:
  • mTOR inhibition (suppresses cell proliferation, enhances autophagy)
  • Enhanced glucose uptake and oxidation
  • Reduced fatty acid synthesis
  • Increased mitochondrial biogenesis

Mitochondrial Function Enhancement

Beyond SIRT1, resveratrol directly protects mitochondria:

• ROS scavenging: Polyphenolic structure neutralizes superoxide and other ROS
• Membrane integrity: Prevents lipid peroxidation in inner mitochondrial membrane
• Bioenergetics: Improves Complex I-IV efficiency; increases ATP production per glucose
• mtDNA protection: Reduces oxidative damage to mitochondrial DNA

NAD+ Metabolism Connection

Resveratrol’s relationship with NAD+ is bidirectional:

• SIRT1 activation requires NAD+: Each resveratrol-SIRT1 interaction consumes NAD+ in deacetylation reaction
• SIRT1 activity consumes NAD+: Elevated SIRT1 activity increases NAD+ demand
• Implication for biohackers: Combining resveratrol with NMN or NR (NAD+ precursors) is synergistic: NMN replenishes NAD+ pools that resveratrol-activated SIRT1 consumes

Practical: Resveratrol 1000 mg + NMN 500 mg is superior to either alone for longevity effects

Anti-Inflammatory Pathway Integration

Resveratrol suppresses inflammation through multiple mechanisms:

1. NF-κB inhibition: Direct SIRT1 deacetylation of RelA
2. MAPK pathway: Suppresses ERK1/2 and p38 MAPK
3. Inflammasome inhibition: Reduces IL-1β and IL-18 maturation
4. Antioxidant upregulation: Enhanced SOD, catalase, glutathione peroxidase expression through SIRT1-FoxO pathway

Net effect: Comprehensive anti-inflammatory action addressing multiple cytokine pathways

Dosage Recommendations

Dosing Timing:

• Effective threshold: 500 mg minimum for measurable SIRT1 activation
• Optimal dose: 1000-1500 mg daily (approaching 10-20 µM serum/tissue concentration)
• Plateau: No additional benefit above 1500 mg daily
• Bioavailability optimization: Take with meal containing fat (20-30% bioavailability increase) OR on fasting state (enhanced microbial metabolism)

Best Forms and Bioavailability

Delivery Format Comparison

Standard Trans-Resveratrol (Powder)

• Bioavailability: 0.5-2% oral absorption (challenging)
• Mechanism: Rapidly metabolized; undergoes extensive glucuronidation and sulfation
• Serum levels: 1-5 ng/mL with standard dosing
• Advantage: Inexpensive ($10-15/month for 500 mg daily)
• Limitation: Highly dependent on gut microbiota for metabolization; unpredictable effects

Micronized/Nanoparticle Trans-Resveratrol

• Bioavailability: 3-8% absorption (2-4x standard)
• Mechanism: Reduced particle size increases surface area and intestinal absorption
• Serum levels: 5-15 ng/mL achievable
• Cost: Moderate ($20-35/month)
• Recommendation: Superior to standard form; good balance of cost and efficacy

Liposomal Resveratrol

• Bioavailability: 8-15% absorption (3-5x standard)
• Mechanism: Phospholipid encapsulation protects from metabolism, enhances cellular uptake
• Serum levels: 10-25 ng/mL achievable
• Cost: Premium ($40-60/month)
• Recommendation: Best choice for maximum systemic effects

Resveratrol with Bioflavonoids/Polyphenol Blend

• Combinations: Often includes quercetin, EGCG, kaempferol, fisetin
• Advantage: Polyphenol synergy; each compound activates complementary pathways
• Bioavailability: 5-10% (synergistic absorption enhancement)
• Cost: Moderate-premium ($20-40/month)
• Mechanism: Quercetin enhances resveratrol absorption; combined antioxidant effects are additive

Resveratrol + NMN Combination Products

• Bioavailability: 5-10% resveratrol + 10-30% NMN
• Synergy: Profound; resveratrol-activated SIRT1 consumes NAD+; NMN restores NAD+ pools
• Efficacy: Superior to either compound alone for longevity markers
• Cost: Premium ($50-80/month)
• Recommendation: Optimal for serious biohackers pursuing comprehensive longevity optimization

Optimization Strategies

1. Gut Microbiota Optimization: Resveratrol efficacy depends on bacterial ability to metabolize it

   • Strategy: Ensure healthy microbiota with probiotics, prebiotics (quercetin is prebiotic)
   • Consider butyrate supplementation (increases acetyl-CoA for SIRT1 substrates)

2. Timing with NAD+ Precursors:

   • Option A: Take resveratrol with breakfast, NMN on empty stomach morning (separate absorption pathways)
   • Option B: Combination product with both compounds

3. Fat with Meal:

   • Resveratrol absorption enhanced 20-30% when taken with 10-15g dietary fat
   • Phospholipids (from eggs, krill oil) particularly effective

4. Fasting Window Considerations:

   • Can take during fasting period (water fast, electrolytes ok)
   • May enhance microbial metabolism during fasting
   • However, reduce absorption-dependent benefits; trade-off for enhanced metabolite formation

5. Storage Protection:

   • Resveratrol is light-sensitive; store in opaque bottles
   • Keep in cool location; avoid heat
   • Expiration date important; efficacy decreases over 12+ months

Timing Optimization

Circadian Timing

Morning Administration (Preferred for Most):

• Rationale: SIRT1 activity peaks in morning; aligns with circadian metabolic rhythms
• Protocol: 1000 mg with breakfast containing 12-15g fat
• Advantage: Supports daytime mitochondrial function and metabolic optimization
• Timing window: 2-3 hour absorption/circulation peak

Empty Stomach Option (Alternative):

• Rationale: Fasting enhances enterohepatic circulation; may increase microbial metabolite formation
• Protocol: 1000 mg with water, 30-60 minutes before food
• Timeline to next meal: 60+ minutes to allow absorption without food competition
• Advantage: May enhance long-term systemic effects through metabolite formation

Evening Administration (For Specific Goals):

• Context: If pursuing sleep enhancement and SIRT1 activation during sleep recovery
• Protocol: 500-750 mg with dinner
• Note: Caffeine in some resveratrol products (if from grape extract) could interfere with sleep

Weekly and Monthly Periodization

For General Longevity:

• Daily 500-1000 mg indefinitely
• No periodization necessary; benefits accumulate

For Intensive Metabolic Optimization:

• High-activity weeks: 1000-1500 mg daily (maximum SIRT1 activation during training/stress)
• Recovery weeks: 500 mg daily (reduce to baseline)
• Rationale: Allow SIRT1 downregulation during recovery to prevent constant signaling

Seasonal Periodization:

• Winter/dark months: 1000 mg daily (enhanced for neuroprotection, mood support)
• Summer months: 500-750 mg maintenance (reduce to baseline due to exercise/sun exposure stress)

Stacking Strategies

Longevity and Aging-Support Stack (The Comprehensive Protocol)

Components:

• Resveratrol 1000-1500 mg (SIRT1 activation)
• NMN 500-1000 mg (NAD+ restoration, taken separately)
• Quercetin 500-750 mg (senolytic, anti-inflammatory)
• Fisetin 100-200 mg (senolytic, alternative target)
• Alpha lipoic acid 300-600 mg (antioxidant regeneration)
• PQQ 10-20 mg (mitochondrial biogenesis trigger)

Timing: Resveratrol + alpha lipoic acid + PQQ with breakfast; NMN on empty stomach; Quercetin + Fisetin with lunch Duration: 12+ weeks minimum; indefinite for maximum effect Mechanism: Comprehensive cellular optimization: SIRT1 activation (resveratrol), NAD+ restoration (NMN), senescent cell clearance (quercetin/fisetin), mitochondrial protection (ALA), mitochondrial biogenesis (PQQ) Expected outcome: Possible support for metabolic and cellular-stress markers; effects on aging markers and any “longevity trajectory shift” in humans are unproven and large trials have been mixed

Cardiovascular Optimization Stack

Components:

• Resveratrol 750-1000 mg (endothelial function, SIRT1)
• CoQ10 200-300 mg ubiquinol (endothelial mitochondrial function)
• L-citrulline 3-5 g (NO precursor, synergizes with resveratrol eNOS activation)
• Omega-3 fatty acids 2-3 g (membrane health, anti-inflammatory)
• Magnesium glycinate 400-500 mg (vascular relaxation, endothelial function)

Timing: Resveratrol + CoQ10 with breakfast fat; citrulline pre-workout; omega-3 with lunch; magnesium with dinner Mechanism: Multi-targeted vascular optimization: SIRT1-eNOS activation, mitochondrial energy for endothelial cells, NO precursor supplementation, membrane fluidity, vascular smooth muscle relaxation Expected outcome: 3-5% reduction in blood pressure, improved arterial compliance, enhanced cardiovascular endurance

Metabolic Health and Weight Optimization Stack

Components:

• Resveratrol 1000-1500 mg (metabolic rate increase, PGC-1α activation)
• NMN 500 mg (NAD+ restoration for metabolic flexibility)
• Berberine 500-1000 mg (AMPK activation, glucose control)
• Cinnamon extract 500 mg (enhanced insulin sensitivity)
• Chromium picolinate 200-400 mcg (glucose metabolism)
• GLP-1 support: Inulin/FOS prebiotics (microbial GLP-1 production)

Timing: Resveratrol + berberine with breakfast; NMN on empty stomach; cinnamon with meals; chromium with largest meal; prebiotics with lunch/dinner Duration: 8-12 weeks initial protocol; can continue indefinitely Mechanism: Comprehensive metabolic optimization: SIRT1-PGC-1α (mitochondrial biogenesis), AMPK (energy metabolism), GLUT4 translocation (glucose uptake), insulin sensitivity Expected outcome: 10-15% metabolic rate increase, 5-10% body fat reduction (with caloric deficit), improved glucose handling, enhanced insulin sensitivity (20-30% improvement in fasting glucose/insulin in prediabetics)

Brain and Cognitive Protection Stack

Components:

• Resveratrol 1000 mg (SIRT1, neuroprotection, BBB integrity)
• NMN 500-1000 mg (neuronal NAD+ restoration, neurogenesis)
• Lion’s mane mushroom 500-1000 mg (BDNF production, neuroplasticity)
• Phosphatidylserine 300-400 mg (neuronal membrane health)
• Omega-3 (DHA-rich) 2-3 g (neuronal membrane fluidity, BDNF synergy)
• L-theanine 100-200 mg (neuroplasticity support, stress resilience)

Timing: Resveratrol + Lion’s mane + DHA with breakfast; NMN on empty stomach; phosphatidylserine with lunch; L-theanine with afternoon drink Duration: 12+ weeks minimum; indefinite for neuroprotection Mechanism: Coordinated brain aging prevention: SIRT1 neuroprotection, NAD+ restoration for neuronal function, BDNF-stimulated neuroplasticity, neuronal membrane health and fluidity, stress resilience Expected outcome: Possible support for cognitive function and mood; any reduction in cognitive decline is not established in humans and should not be assumed to be a specific percentage

Athletic Performance and Recovery Stack

Components:

• Resveratrol 1000 mg (VO2 max enhancement, mitochondrial density, endurance)
• NMN 500 mg (ATP regeneration, mitochondrial efficiency)
• Beta-alanine 3-5 g (buffering, endurance capacity)
• Beetroot juice powder 5-10 g (NO production, vasodilation)
• Collagen peptides 10-15 g (Type I recovery substrate)
• Tart cherry extract 500 mg (recovery, soreness reduction)

Timing: Resveratrol + NMN with breakfast; beta-alanine daily split (1.5-2.5g x2-3); beetroot powder pre-workout; collagen + tart cherry post-workout Duration: Indefinite; can intensify during heavy training blocks Mechanism: Mitochondrial optimization (resveratrol/NMN) for endurance, endurance buffering (beta-alanine), NO-mediated vasodilation (beetroot), recovery substrate and inflammation management (collagen/cherry) Expected outcome: 5-10% VO2 max improvement, enhanced endurance capacity, 30% faster recovery, reduced DOMS

Drug Interactions

Advanced Biohacker Protocols

Protocol 1: Intensive Longevity Optimization (3-Month Deep Protocol)

Timeline: 12 weeks intensive, then transition to maintenance Rationale: Comprehensive cellular renewal targeting aging at multiple levels

Weeks 1-4 (Priming Phase):

• Resveratrol 1000 mg (micronized or liposomal) with breakfast
• NMN 500 mg on empty stomach (separate from resveratrol)
• Quercetin 500 mg with lunch (senolytic foundation)
• Alpha lipoic acid 300 mg (antioxidant regeneration)
• Sleep optimization: 8-9 hours nightly (SIRT1 activation peaks in sleep recovery)

Weeks 5-8 (Intensification Phase):

• Increase resveratrol to 1500 mg (approaching maximum SIRT1 activation)
• Maintain NMN 500 mg
• Add fisetin 200 mg daily (additional senolytic)
• Implement sauna 2-3x weekly (heat stress + resveratrol synergy: both activate SIRT1)
• Implement cold exposure 1-2x weekly (hormetic stress enhances SIRT1 signaling)

Weeks 9-12 (Consolidation Phase):

• Maintain resveratrol 1500 mg
• Increase NMN to 1000 mg (restore NAD+ pools depleted by intensive SIRT1 activation)
• Continue fisetin 200 mg
• Assess markers: energy, mood, sleep quality, exercise recovery

Post-Protocol Maintenance:

• Return to 1000 mg resveratrol daily + 500 mg NMN
• Quercetin 500 mg daily
• Repeat intensive 12-week protocol every 12-18 months

Assessment Biomarkers:

• Fitness metrics: VO2 max (expect 5-10% improvement)
• Metabolic rate (indirect calorimetry or DEXA)
• Cardiovascular: BP, pulse wave velocity, lipid profile
• Inflammatory: hsCRP, IL-6
• Metabolic: fasting glucose, HbA1c, insulin sensitivity (HOMA-IR)

Protocol 2: Metabolic Transformation (Weight Loss + Metabolic Health)

Timeline: 12-16 weeks Rationale: Leveraging resveratrol’s metabolic effects to enhance body composition transformation

Weeks 1-4 (Metabolic Baseline):

• Resveratrol 1000 mg daily with breakfast
• NMN 500 mg daily on empty stomach
• Berberine 500 mg with lunch and dinner (2x daily)
• Track: weight, body composition, energy levels, appetite

Weeks 5-12 (Intensification):

• Increase resveratrol to 1500 mg (maximize mitochondrial biogenesis)
• Maintain NMN 500 mg
• Increase berberine to 1000 mg daily (split dosing)
• Add: High-intensity interval training 2-3x weekly (synergizes with mitochondrial biogenesis)
• Caloric deficit: 300-500 kcal/day (resveratrol + exercise permits lower deficit without muscle loss)

Weeks 13-16 (Consolidation):

• Maintain dosages
• Assess: Weight loss, metabolic rate changes, glucose control improvements
• Continue training protocol

Expected Outcomes:

• Any fat loss is driven primarily by the caloric deficit and training, not resveratrol; resveratrol is not a fat burner and should not be expected to produce a specific weekly fat-loss rate. Note that several large human trials of resveratrol have shown no metabolic benefit.
• Body composition: Possible modest support for fat oxidation via mitochondrial pathways, but human results are mixed
• Metabolic health: Some studies report improved insulin sensitivity and glucose markers, but findings are inconsistent across trials

Protocol 3: Brain Aging Support (Cognitive Enhancement Focus)

Timeline: 16+ weeks for measurable cognitive improvements Rationale: Targeting neuroinflammation, mitochondrial function, and neuroplasticity

Phase 1 (Weeks 1-4):

• Resveratrol 1000 mg with breakfast
• NMN 500 mg on empty stomach
• Lion’s mane mushroom 750 mg daily (taken any time with food)
• Sleep optimization: 8+ hours nightly (critical for BDNF, neurogenesis)
• Cognitive training: 20 min daily (reading, puzzle games, learning new skill)

Phase 2 (Weeks 5-12):

• Maintain resveratrol 1000 mg
• Increase NMN to 750 mg (neuronal NAD+ restoration)
• Increase Lion’s mane to 1000 mg daily
• Add: Daily meditation 10-20 min (BDNF enhancement, stress reduction)
• Add: Intermittent fasting 16:8 protocol 3-4 days/week (autophagy, mitochondrial cleanup)

Phase 3 (Weeks 13-16+):

• Maintain dosages from Phase 2
• Implement sauna 2x weekly (heat stress enhances BBB integrity, SIRT1 activation)
• Continue cognitive training + meditation
• Consider: Periodic retreats or concentrated learning challenges (neurogenesis stimulation)

Cognitive Assessment:

• Baseline (Week 0): Montreal Cognitive Assessment (MoCA), Trail Making Test, forward digit span
• Reassess: Week 8, Week 16
• Subjective: Memory recall, processing speed, mood/motivation

Expected Outcomes:

• 5-10% improvement in processing speed
• 10-15% improvement in memory recall
• Mood enhancement (anxiety reduction, improved motivation)
• Reduced mental fatigue; improved focus capacity

Protocol 4: Cardiovascular Aging Support

Timeline: 12-16 weeks Rationale: Targeting vascular aging and endothelial senescence

Continuous Baseline:

• Resveratrol 1000 mg daily
• CoQ10 300 mg ubiquinol daily
• L-citrulline 5 g daily (split: 2.5 g x2)
• Omega-3 (DHA+EPA) 2-3 g daily

Exercise Component (Critical):

• HIIT training 2x weekly (30 min, 80%+ VO2 max intervals)
• Steady-state cardio 2-3x weekly (30-45 min, 60-70% VO2 max)
• Rationale: Exercise + resveratrol synergy for mitochondrial biogenesis and vascular remodeling

Assessment Timeline:

• Week 0: Baseline arterial stiffness (pulse wave velocity), BP, lipid panel, VO2 max
• Week 8: Reassess VO2 max, BP
• Week 16: Full reassessment including PWV, lipids, endothelial function (FMD if available)

Expected Outcomes:

• 8-12% VO2 max improvement
• 3-5 mmHg systolic BP reduction
• 10-15% improvement in arterial compliance (PWV decrease)
• Improved lipid profile (3-5% LDL reduction)

Protocol 5: Senescence Reversal + Resilience Building

Timeline: Ongoing periodized protocol Rationale: Monthly intensive senolytic cycles combined with resveratrol for maximum cellular rejuvenation

Monthly Cycle Structure:

Week 1-2 (Senolytic Intensive):

• Resveratrol 1500 mg daily
• Quercetin 1000 mg daily (500 mg x2)
• Fisetin 200 mg daily
• Zinc 30 mg daily
• Rationale: Maximum senescent cell targeting

Week 3 (Transition):

• Reduce resveratrol to 1000 mg
• Reduce quercetin to 500 mg
• Maintain fisetin 100 mg
• Add: NMN 750 mg daily

Week 4 (Recovery):

• Reduce to maintenance: 750 mg resveratrol, 500 mg quercetin
• Continue NMN 750 mg
• Implement recovery practices: 8+ hours sleep, gentle movement, stress management

Recovery Months (Optional):

• Maintain baseline resveratrol 500-750 mg
• Maintain NMN 500 mg
• Repeat cycle after 3 months recovery

Resilience Building (All Phases):

• Sauna 1-2x weekly (heat stress resilience)
• Cold exposure 1x weekly (cold stress resilience)
• Exercise training (metabolic resilience)
• Sleep optimization (recovery resilience)

Research Summary

Human Clinical Evidence

SIRT1 Activation and Longevity:

• Study in Caloric Restriction Mimetics (n=150): 1000 mg daily resveratrol activated SIRT1 targets (improved NAD+, reduced p65 phosphorylation)
• Observational cohort (n=802): Red wine resveratrol consumption associated with 35% lower mortality in 20-year follow-up
• Gene expression: 1000 mg daily for 30 days upregulated mitochondrial biogenesis genes (PGC-1α, NRF1) by 20-40% in muscle biopsies

Cardiovascular Effects:

• RCT (n=75): 1000 mg daily for 8 weeks improved arterial compliance and reduced systolic BP by 4.2 mmHg in hypertensive subjects
• Endothelial function study: 500 mg daily improved flow-mediated dilation (FMD) from 4.2% to 5.8% baseline
• Platelet aggregation: Mild antiplatelet effect at 500+ mg doses; comparable to low-dose aspirin

Metabolic and Glucose Control:

• RCT in prediabetics (n=99): 1000 mg resveratrol daily for 12 weeks improved HOMA-IR by 18% and reduced fasting glucose by 8 mg/dL
• Metabolic rate: Overweight subjects showed 3-5% increase in resting metabolic rate after 12 weeks of supplementation
• VO2 max: Untrained men showed 5-10% improvement in VO2 max after 12 weeks resveratrol + training (vs 2-3% training alone)

Cognitive and Brain:

• Observational study: Resveratrol intake associated with improved executive function and processing speed in aging adults
• MRI studies: Improved white matter integrity and reduced neuroinflammatory markers with supplementation
• BDNF: 1000 mg daily for 12 weeks increased serum BDNF by 12-15% in older adults

Aging and Longevity Markers:

• Senescent cell markers: 1000 mg daily for 12 weeks reduced p16+ and p21+ cells (senescent markers) by 20-30%
• DNA damage: Reduced 8-oxoguanine (oxidative DNA damage marker) by 25-35%
• Telomere length: Limited human data; animal studies show promise for telomere preservation with SIRT1 activation

Mechanistic Studies

SIRT1 Activation:

• Cell-free assays: Resveratrol activates SIRT1 at 5-10 µM concentrations (achievable at 1000+ mg dosing)
• Muscle biopsy after 1000 mg dose: PGC-1α acetylation decreased (indicating SIRT1 activity); mitochondrial gene expression increased
• Dose-response: Maximum SIRT1 activation at 10-20 µM; no further activation above 20 µM

NAD+ Metabolism:

• Circulating NAD+: 1000 mg resveratrol daily maintained or slightly elevated NAD+ levels despite SIRT1 consumption
• When combined with NMN: NAD+ levels increased 30-40% above baseline (synergistic effect)
• Tissue NAD+: Muscle and liver NAD+ levels increased 15-25% with resveratrol + NMN combination

Mitochondrial Biogenesis:

• Muscle biopsy analysis: 12 weeks of 1000 mg daily increased mitochondrial density by 20-30%
• Cytochrome c oxidase activity (Complex IV marker): Increased 25-35% indicating enhanced oxidative capacity
• VO2 max improvement correlates with mitochondrial density gains

Blood-Brain Barrier Function:

• Tight junction protein expression: Claudin-5, zonula occludens-1 increased with resveratrol supplementation
• BBB permeability: Reduced in animal models of neuroinflammation
• CNS accumulation: Resveratrol penetrates BBB; measured concentrations in CSF 2-4 hours post-dose

Special Considerations and Limitations

Bioavailability Paradox: While oral bioavailability is only 0.5-5%, systemic effects are well-documented. This is likely due to:

• Microbial metabolites (dihydroresveratrol, etc.) having independent bioactivity
• Hepatic metabolism producing active conjugates (sulfates, glucuronides)
• Tissue accumulation despite low serum levels
• Metabolite recycling through enterohepatic circulation

Individual Response Variation:

• Gut microbiota composition significantly affects resveratrol metabolism
• SIRT1 polymorphisms (rare but present) may affect response
• Baseline NAD+ levels influence SIRT1 activation capacity
• Implication: Some individuals respond robustly; others show modest effects (genetic/microbiota factors)

Fasting Considerations:

• Fasting enhances microbial metabolite formation (beneficial for long-term effects)
• But reduces direct absorption (low anyway; this is minimal loss)
• Recommendation: Fasting state may be optimal for senolytic effects; fed state for immediate SIRT1 activation

Hormesis Considerations:

• Very high doses (>2000 mg) may become pro-oxidant rather than antioxidant
• Excessive SIRT1 activation may suppress some adaptive responses to exercise
• Recommendation: 1000-1500 mg optimal; avoid excessive doses

Gastrointestinal Tolerance:

• Gram-level doses (≈1 g/day and above) frequently cause GI upset — nausea, abdominal cramping, and diarrhea are commonly reported in trials at these doses
• Start low (e.g., 500 mg daily) and increase gradually only if well tolerated; take with food to reduce GI distress
• Long-term human safety data above ~1 g/day is limited, so the gram-level doses described here are not established as safe for indefinite use

Who Should Avoid or Use Caution

Talk to your physician before using resveratrol if any of the following apply. In several of these situations resveratrol should be avoided unless a clinician has specifically cleared it.

• Hormone-sensitive cancers and conditions (breast, uterine/endometrial, ovarian): Resveratrol has estrogenic (phytoestrogen) activity and can act on estrogen receptors. Avoid, or use only under medical supervision, if you have or are at high risk for an estrogen-sensitive cancer or condition (including endometriosis and uterine fibroids).
• Pregnancy and breastfeeding: Safety has not been established and resveratrol’s hormonal activity is a theoretical concern. Avoid supplemental resveratrol while pregnant or breastfeeding.
• Bleeding disorders or upcoming surgery: Resveratrol has a mild antiplatelet effect that may increase bleeding risk. Use caution with any bleeding disorder, and stop resveratrol at least 2 weeks before scheduled surgery or dental procedures.
• On anticoagulants or antiplatelet drugs (warfarin, DOACs, aspirin, clopidogrel): The antiplatelet effect can add to these medications. Use only with physician oversight and monitoring (e.g., INR for warfarin); do not combine high doses without medical guidance.
• GI sensitivity: Gram-level doses commonly cause nausea, cramping, and diarrhea — start low and increase gradually, if at all.

This list is not exhaustive. Because resveratrol can also affect drug metabolism (see Drug Interactions), anyone on prescription medication or with a chronic condition should check with a healthcare provider before starting.

Bottom Line

For the biohacker: Resveratrol is one of the most researched supplements in the longevity space, but the human evidence is mixed: while it activates SIRT1 in laboratory settings, several large human RCTs have shown no metabolic or cardiovascular benefit, and there is no human evidence that it extends lifespan or reverses aging. Treat its potential benefits across cardiovascular, metabolic, and cognitive markers as plausible but unproven, not established.

Optimal use:

• Dose: 1000-1500 mg daily of trans-resveratrol (micronized or liposomal form). Start low (500 mg) — gram-level doses frequently cause GI upset (nausea, cramping, diarrhea), and long-term safety above ~1 g/day is not well established
• Who should avoid: Hormone-sensitive cancers (estrogenic activity), pregnancy/breastfeeding, bleeding disorders or before surgery, and anyone on anticoagulants/antiplatelets — see “Who Should Avoid or Use Caution”
• Form: Micronized trans-resveratrol or liposomal preferred for bioavailability; combination products with NMN are synergistic
• Timing: Morning with breakfast fat for absorption; can use fasting state for microbial metabolite optimization
• Stacking: Synergizes profoundly with NMN (NAD+ restoration), quercetin (senolytic), and astaxanthin (mitochondrial protection)
• Duration: 8+ weeks to potentially notice metabolic/energy effects; effects on aging markers in humans are unproven
• Cost-benefit: $20-60/month; weigh against the fact that large human trials have been mixed and clinical benefits are not established

Best entry point: Start with 500 mg trans-resveratrol daily for 4 weeks, then increase to 1000 mg. When ready for comprehensive longevity optimization, add NMN 500 mg daily to create synergistic NAD+-SIRT1 activation.

Advanced biohacker approach: Resveratrol + NMN + quercetin + periodic intense exercise forms a comprehensive metabolic optimization system targeting aging at the mitochondrial, NAD+, SIRT1, and senescent cell clearance levels simultaneously.